Use of n-(indolecarbonyl)piperazine derivatives

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61P 3/04 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01) A61P 25/20 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01) C07D 209/42 (2006.01)

Patent

CA 2468380

The invention relates to the use of compounds of formula (I), wherein R1, R2, R4 and R5 have the designations cited in patent claim 1, and to the physiologically acceptable salts and solvates of said compounds, for the treatment of obesity, sub-types of anxiety, sub-types of schizophrenia and types of dementia of various origins.

Utilisation de composés de formule (I) dans laquelle R?1¿, R?2¿, R?4¿ et R?5¿ possèdent les significations figurant dans la revendication 1, ainsi que de sels et solvats physiologiquement acceptables desdits composés pour traiter l'adipose, des sous-types de l'angoisse, des sous-types de la schizophrénie et des types de démence d'origine diverse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of n-(indolecarbonyl)piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of n-(indolecarbonyl)piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of n-(indolecarbonyl)piperazine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1597814

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.